NOVATO, Calif. — November 24, 2025 — Leads & Copy — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) will participate in two upcoming investor conferences.
Dr. Eric Crombez, Chief Medical Officer, will participate in a fireside chat at Citi’s 2025 Global Healthcare Conference in Miami, Florida, on Tuesday, December 2, 2025.
Crombez will also participate in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference in Coral Gables, Florida, on Wednesday, December 3, 2025.
The live and archived webcasts of the fireside chats will be available on the company’s website.
Ultragenyx is focused on developing and commercializing novel therapies for serious rare and ultra-rare genetic diseases. The company has a portfolio of approved therapies and product candidates targeting diseases with high unmet medical needs.
Ultragenyx aims to deliver safe and effective therapies to patients with urgency, utilizing time- and cost-efficient drug development strategies.
Joshua Higa, Investor Relations, can be reached at ir@ultragenyx.com.
Source: Ultragenyx Pharmaceutical Inc.
Source: Ultragenyx Pharmaceutical Inc.
